Matt Lipscomb

Founder @ DMC Biotechnologies arrow icon

About Matt Lipscomb

Matt Lipscomb, Ph.D., is the founder and a former founding employee of OPX Biotechnologies, known for his leadership in a DOE ARPA-E Electrofuels program focused on biodiesel production.

Known information

Matt Lipscomb, who holds a Ph.D., is recognized for his foundational role and contributions at OPX Biotechnologies, where he was a founding employee. He played a pivotal role in leading a project under the Department of Energy’s ARPA-E Electrofuels program, which successfully developed a process for producing biodiesel from hydrogen and carbon dioxide. Lipscomb’s technical expertise spans several critical areas including microbial fermentation, process development, process modeling, analytical chemistry, and techno-economic analysis of bio-based processes. His work primarily focuses on advancing technologies that leverage biological processes for sustainable fuel production.

About DMC Biotechnologies

DMC Biotechnologies produces sustainable bio-based chemicals using precision fermentation technology, with a focus on flavors, fragrances, and ingredients like L-alanine and xylitol.

report flag Report inaccurate information

People similar to Matt Lipscomb

Kenny Erdoes is the CEO with over 20 years of experience in process engineering, project development, and manufacturing operations, specializing as a chemical engineer.

Mike Lynch is an assistant professor at Duke University and the founder of OPX Biotechnologies, Inc., known for his pioneering work in biocatalyst engineering and synthetic metabolic technologies.

Rob van der Meij is a chemical engineer and experienced business leader with a background in chemicals, process, and water technology sectors.

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free